Eisai Bid To Affirm Validity Refused In Aricept Suit
A federal judge has refused to affirm validity for a patent at the center of a dispute over Teva Pharmaceutical Industries Ltd.'s efforts to make a generic version of Aricept, Eisai...To view the full article, register now.
Already a subscriber? Click here to view full article